Feature | October 26, 2011| Dave Fornell

TAVI ROI Will Come From Surgical Referrals, Not TAVI

The Cardiopulmonary Research Science and Technology Institute (CRSTI) in Dallas, Texas, created two hybrid operating rooms (ORs) specifically for participation in the PARTNER trial for Edwards Sapien transcatheter aortic valve. The center has implanted more than 200 Sapien valves since it started in the trial in 2006.


Angela Riley, RT, CRSTI executive director, said the cost of transcatheter aortic valve implantation (TAVI) and the build out of the hybrid ORs will be prohibitive for most hospitals and the return on investment (ROI) is low. However, she said patients are drawn to facilities offering TAVI.


She said patient selection for TAVI is critical and many patients do not qualify. Her center screens four patients to get one who is suitable for TAVI. Most of those turned away undergo surgical valve replacement. While this is not a good ratio to base return on investment (ROI) for building a TAVI program, Riley said the real returns have come from tripling surgical referrals.


A better strategy to sell the costs of a TAVI program to hospital administrators is not to base ROI on TAVI procedures, but on the increased surgical valve repair volume from the referrals. “Even if patients do not qualify, they will usually stay with your hospital for other treatments,” she explained.

Related Content

melody valve

Max Page and his father Buck share a pre-operation moment on morning of July 30 Melody transcatheter valve procedure at Children's Hospital Los Angeles.

News | Structural Heart| August 28, 2015
August 28, 2015 — Cardiologists from Children’s Hospital Los Angeles successfully implanted a...
News | Cath Lab| August 26, 2015
August 26, 2014 — The Cardiovascular Research Foundation (CRF) announced the late-breaking trials and first report in

Mitral regurgitation viewed under color Doppler. Image courtesy of Toshiba.

Feature | Heart Valve Repair| August 26, 2015
August 25, 2015 — Medtronic announced it entered a definitive agreement to acquire Twelve Inc., a start–up medical de
NuCART, CompView Medical, mobile boom system, cath lab, hybrid OR
Technology | Cath Lab| August 21, 2015
August 21, 2015 — CompView Medical announced the release of the NuCART, a turn-key, all-in-one mobile boom system wit
Medtronic, CoreValve Evolut R, Loyola University Medical Center, first in Illinois, SURTAVI, EUS
News | Heart Valve Repair| August 19, 2015
Loyola University Medical Center is the first center in Illinois to implant the CoreValve Evolut R percutaneous aortic...
Sponsored Content | Videos | Computed Tomography (CT)| August 07, 2015
DAIC Editor Dave Fornell shares some of the most innovative new technologies shown on the expo floor and discusses in
Sponsored Content | Videos | 3-D Printing| August 05, 2015
Interview with Dee Dee Wang, M.D., FACC, FASE, advanced structural heart imaging staff cardiologist, Henry Ford Hospi
Abbott, purchase, Tendyne Holdings Inc., Cephea Valve Technologies, mitral valve therapies
News | Heart Valve Repair| August 05, 2015
Abbott announced Monday that it has entered into an agreement to purchase Tendyne Holdings Inc., a private medical...
Feature | Heart Valve Repair| July 28, 2015
Boston Scientific announced CE Mark and U.S. Food and Drug Administration (FDA) clearance for the Safari2 Pre-Shaped...
Products | Guidewires| July 28, 2015
The Safari2 Pre-Shaped Guidewire.
Overlay Init